Thomas Freour/LinkedIn
Nov 17, 2025, 17:09
Thomas Freour: Single-Cell Technologies Poised to Transform Understanding of Early Embryogenesis
Thomas Freour, Clinical embryologist, Head of ART Department at University Hospital of Nantes-France, shared a post on LinkedIn:
“Glad that our mini-review on single-cell omics and their contribution to improve knowledge on human early embryo development finally came out in Human Reproduction journal. Hopefully this will serve as a resource for all those interested in basic (and clinical) human embryology.
Great work Océane GIRARD Eva Moinard Laurent DAVID!!!”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Sep 19, 2026, 17:48Gaurav Gangwani: 40% of Infertile Men Have Varicocele, but Some Fertility Doctors Don’t Screen for It Routinely
-
Sep 19, 2026, 17:45Steven Leist: No One Should Have to Navigate the Path to Parenthood Alone
-
Sep 19, 2026, 17:43Gautam Allahbadia: An Embryo’s Journey Doesn’t Always Follow a Perfectly Predictable Path
-
Sep 19, 2026, 17:41Aumatma Simmons: Fertility Progress Isn’t Always All-or-Nothing
-
Sep 19, 2026, 17:37Emre Seli: Useful Information for Counseling Patients After an IVF Cycle with Complete Embryo Developmental Arrest
-
Sep 19, 2026, 17:34Lucas Almoño: When a Team Is Built with Outstanding People, the Impact Is Even Greater
-
Sep 19, 2026, 17:31MEFS 2026 Is Where Knowledge Moves Forward
-
Sep 19, 2026, 17:30Baroness Geeta Nargund: Speaking About the Urgent Need for Fertility Education in the UK House of Lords
-
Sep 19, 2026, 17:27Mahnaz Fida: Beyond IVF – A Patient-Centred Journey from Fertility Assessment to Parenthood
